Document ID: 16639

Text:
(r) Equity Capitalization. As of the date hereof, the authorized capital stock of the Company consists of (i) 100,000,000 shares of Common Stock, of which as of the date hereof, 33,046,364 shares are issued and outstanding, 26,602,702 shares are reserved for issuance pursuant to the Companys stock option and purchase plans and 197,536,831 shares are reserved for issuance pursuant to securities (other than the aforementioned options and the Offered Notes) exercisable or exchangeable for, or convertible into, Common Stock, and (ii) 10,000,000 shares of preferred stock, par value $0.001 per share, of which as of the date hereof 10 shares are issued and outstanding as of the date hereof. No shares of Common Stock are held in treasury and all of such outstanding shares are duly authorized and have been, or upon issuance will be, validly issued and are fully paid and nonassessable. (i) None of the Companys or any Subsidiarys capital stock is subject to preemptive rights or any other similar rights or any liens or encumbrances suffered or permitted by the Company or any Subsidiary; (ii) except as disclosed in Schedule 3(r)(ii), there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional shares or capital stock of the Company or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company or any of its Subsidiaries; (iii) except as disclosed in Schedule 3(r)(iii), there are no outstanding debt securities, notes, credit agreements, credit facilities or other agreements, documents or instruments evidencing Indebtedness of the Company or any of its Subsidiaries or by which the Company or any of its Subsidiaries is or may become bound; (iv) there are no financing statements securing obligations in any material amounts filed in connection with the Company or any of its Subsidiaries; (v) except as disclosed in Schedule 3(r)(v), there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any of their securities under the 1933 Act ( except pursuant to the Registration Rights Agreement); (vi) there are no outstanding securities or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem a security of the Company or any of its Subsidiaries; (vii) except as disclosed in Schedule 3(r)(vii), there are no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the Securities; (viii) neither the Company nor any Subsidiary has any stock appreciation rights or phantom stock plans or agreements or any similar plan or agreement; and (ix) neither the Company nor any Subsidiary has any liabilities or obligations required to be disclosed in the SEC Documents but not so disclosed in the SEC Documents, other than those incurred in the ordinary course of the Companys or any of its Subsidiarys respective businesses and which, individually or in the aggregate, do not or would not have a Material Adverse Effect. The Company has furnished or made available to the Buyers true, correct and complete copies of the Companys Articles of Incorporation, as amended and as in effect on the date hereof (the Articles of Incorporation), and the Companys Bylaws, as amended and as in effect on the date hereof (the Bylaws), and the terms of all securities convertible into, or exercisable or exchangeable for shares of Common Stock and the material rights of the holders thereof in respect thereto.

Named Entities:
24
28
Shares
42
46
Shares
53
57
Shares
73
77
Shares
113
117
Shares
125
128
Price
512
513
Act
519
521
Shares
742
744
Title
758
760
Title
766
766
Title
780
780
Title

Tokenized Text:
(
r
)
Equity
Capitalization
.
As
of
the
date
hereof
,
the
authorized
capital
stock
of
the
Company
consists
of
(
i
)
100
,
000
,
000
shares
of
Common
Stock
,
of
which
as
of
the
date
hereof
,
33
,
046
,
364
shares
are
issued
and
outstanding
,
26
,
602
,
702
shares
are
reserved
for
issuance
pursuant
to
the
Companys
stock
option
and
purchase
plans
and
197
,
536
,
831
shares
are
reserved
for
issuance
pursuant
to
securities
(
other
than
the
aforementioned
options
and
the
Offered
Notes
)
exercisable
or
exchangeable
for
,
or
convertible
into
,
Common
Stock
,
and
(
ii
)
10
,
000
,
000
shares
of
preferred
stock
,
par
value
$
0
.
001
per
share
,
of
which
as
of
the
date
hereof
10
shares
are
issued
and
outstanding
as
of
the
date
hereof
.
No
shares
of
Common
Stock
are
held
in
treasury
and
all
of
such
outstanding
shares
are
duly
authorized
and
have
been
,
or
upon
issuance
will
be
,
validly
issued
and
are
fully
paid
and
nonassessable
.
(
i
)
None
of
the
Companys
or
any
Subsidiarys
capital
stock
is
subject
to
preemptive
rights
or
any
other
similar
rights
or
any
liens
or
encumbrances
suffered
or
permitted
by
the
Company
or
any
Subsidiary
;
(
ii
)
except
as
disclosed
in
Schedule
3
(
r
)
(
ii
)
,
there
are
no
outstanding
options
,
warrants
,
scrip
,
rights
to
subscribe
to
,
calls
or
commitments
of
any
character
whatsoever
relating
to
,
or
securities
or
rights
convertible
into
,
or
exercisable
or
exchangeable
for
,
any
shares
of
capital
stock
of
the
Company
or
any
of
its
Subsidiaries
,
or
contracts
,
commitments
,
understandings
or
arrangements
by
which
the
Company
or
any
of
its
Subsidiaries
is
or
may
become
bound
to
issue
additional
shares
or
capital
stock
of
the
Company
or
any
of
its
Subsidiaries
or
options
,
warrants
,
scrip
,
rights
to
subscribe
to
,
calls
or
commitments
of
any
character
whatsoever
relating
to
,
or
securities
or
rights
convertible
into
,
or
exercisable
or
exchangeable
for
,
any
shares
of
capital
stock
of
the
Company
or
any
of
its
Subsidiaries
;
(
iii
)
except
as
disclosed
in
Schedule
3
(
r
)
(
iii
)
,
there
are
no
outstanding
debt
securities
,
notes
,
credit
agreements
,
credit
facilities
or
other
agreements
,
documents
or
instruments
evidencing
Indebtedness
of
the
Company
or
any
of
its
Subsidiaries
or
by
which
the
Company
or
any
of
its
Subsidiaries
is
or
may
become
bound
;
(
iv
)
there
are
no
financing
statements
securing
obligations
in
any
material
amounts
filed
in
connection
with
the
Company
or
any
of
its
Subsidiaries
;
(
v
)
except
as
disclosed
in
Schedule
3
(
r
)
(
v
)
,
there
are
no
agreements
or
arrangements
under
which
the
Company
or
any
of
its
Subsidiaries
is
obligated
to
register
the
sale
of
any
of
their
securities
under
the
1933
Act
(
except
pursuant
to
the
Registration
Rights
Agreement
)
;
(
vi
)
there
are
no
outstanding
securities
or
instruments
of
the
Company
or
any
of
its
Subsidiaries
which
contain
any
redemption
or
similar
provisions
,
and
there
are
no
contracts
,
commitments
,
understandings
or
arrangements
by
which
the
Company
or
any
of
its
Subsidiaries
is
or
may
become
bound
to
redeem
a
security
of
the
Company
or
any
of
its
Subsidiaries
;
(
vii
)
except
as
disclosed
in
Schedule
3
(
r
)
(
vii
)
,
there
are
no
securities
or
instruments
containing
anti-dilution
or
similar
provisions
that
will
be
triggered
by
the
issuance
of
the
Securities
;
(
viii
)
neither
the
Company
nor
any
Subsidiary
has
any
stock
appreciation
rights
or
phantom
stock
plans
or
agreements
or
any
similar
plan
or
agreement
;
and
(
ix
)
neither
the
Company
nor
any
Subsidiary
has
any
liabilities
or
obligations
required
to
be
disclosed
in
the
SEC
Documents
but
not
so
disclosed
in
the
SEC
Documents
,
other
than
those
incurred
in
the
ordinary
course
of
the
Companys
or
any
of
its
Subsidiarys
respective
businesses
and
which
,
individually
or
in
the
aggregate
,
do
not
or
would
not
have
a
Material
Adverse
Effect
.
The
Company
has
furnished
or
made
available
to
the
Buyers
true
,
correct
and
complete
copies
of
the
Companys
Articles
of
Incorporation
,
as
amended
and
as
in
effect
on
the
date
hereof
(
the
Articles
of
Incorporation
)
,
and
the
Companys
Bylaws
,
as
amended
and
as
in
effect
on
the
date
hereof
(
the
Bylaws
)
,
and
the
terms
of
all
securities
convertible
into
,
or
exercisable
or
exchangeable
for
shares
of
Common
Stock
and
the
material
rights
of
the
holders
thereof
in
respect
thereto
.